It’s been a volatile time for markets, as world politics play out against a seemingly ever-changing backdrop. Milford Portfolio Manager...
The S&P 500 index is down 9.3% from its peak, amid growing concerns of slowing US economic growth. Milford Senior...
USA, a bit less exceptional
February saw a sharp change in tone for markets. Share markets sold-off,...
CNP – an attractive US utility in a high growth jurisdiction
When we make investments in infrastructure companies at...
Earnings season confirmed that the second half of 2024 was a tough period for New Zealand companies. Milford Investment Analyst...
Ryman Healthcare is conducting a second capital raise, asking the market for 1bn. Milford Investment Analyst Jeremy Hutton talks to...
This article was originally published in the NZ Herald on 24 February 2025.
In this episode of Invest in Yourself...
The RBNZ cut the ORC by 50 basis points this week, as the market expected, however it also forecast two...
It’s reporting season for NZX-listed companies, with market expectations low after a tough second half of 2024. Milford Investment Analyst...
